Search results
Pages
-
- Differential O- and glycosphingolipid glycosylation in human pancreatic adenocarcinoma cells with opposite morphology and metastatic behavior
-
- Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging
-
- Evaluation of sibling and twin fragment ions improves the structural characterization of proteins by top-down MALDI in-source decay mass spectrometry
-
- Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype
-
- A matrix-assisted laser desorption/ionization-mass spectrometry assay for the relative quantitation of antennary fucosylated N-glycans in human plasma
-
- Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases
-
- Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy
-
- Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation
-
- Metformin and statin use associate with plasma proteinN-glycosylation in people with type 2 diabetes
-
- Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
-
- Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry
-
- A matrix-assisted laser desorption/ionization—mass spectrometry assay for the relative quantitation of antennary fucosylated N-glycans in human plasma